Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous hematopoietic stem cell transplantation for achieving organ transplant tolerance; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complication of Transplanted Organ Nos

Snippet

Sponsor: Gary A Levy, O. Ont. MD. FRCP AGAF | Conditions: Complication of Transplanted Organ, Nos | Phase 2 | Status: COMPLETED